Your browser doesn't support javascript.
COVID-19 in the least developed, fragile, and conflict-affected countries - How can the most vulnerable be protected?
Ebrahim, Shahul H; Gozzer, Ernesto; Ahmed, Yusuf; Imtiaz, Rubina; Ditekemena, John; Rahman, N M Mujeeb; Schlagenhauf, Patricia; Alqahtani, Saleh A; Memish, Ziad A.
  • Ebrahim SH; University of Sciences, Technique and Technology, Bamako, Mali. Electronic address: ebrahimsh2@gmail.com.
  • Gozzer E; Universidad Peruana Cayetano Heredia, Lima, Peru. Electronic address: ernesto.gozzer@upch.pe.
  • Ahmed Y; University Teaching Hospitals and Levy Mwanawasa Medical University, Lusaka, Zambia. Electronic address: yusufahmed03@hotmail.com.
  • Imtiaz R; Children Without Worms, Task Force for Global Health, Decatur, GA, USA. Electronic address: rimtiaz@taskforce.org.
  • Ditekemena J; Kinshasa School of Public Health, Faculty of Medicine, University of Kinshasa, Kinshasa, Congo; Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon. Electronic address: jditekemena@pedaids.com.
  • Rahman NMM; MES Medical College Hospital, Perinthalmanna, India. Electronic address: drnmmujeeb@mesams.com.
  • Schlagenhauf P; University of Zürich Centre for Travel Medicine, WHO Collaborating Centre for Travellers' Health, Department of Public and Global Health, Institute for Epidemiology, Biostatistics and Prevention, Zürich, Switzerland. Electronic address: Patricia.Schlagenhauf@uzh.ch.
  • Alqahtani SA; Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; Division of Gastroenterology and Hepatology, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: Salqaht1@jhmi.edu.
  • Memish ZA; Research and Innovation Center, King Saud Medical City, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. Electronic address: zmemish@yahoo.com.
Int J Infect Dis ; 102: 381-388, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-954501
ABSTRACT
The relentless spread of coronavirus disease 2019 (COVID-19) and its penetration into the least developed, fragile, and conflict-affected countries (LDFCAC) is a certainty. Expansion of the pandemic will be expedited by factors such as an abundance of at-risk populations, inadequate COVID-19 mitigation efforts, sheer inability to comply with community mitigation strategies, and constrained national preparedness. This situation will reduce the benefits achieved through decades of disease control and health promotion measures, and the economic progress made during periods of global development. Without interventions, and as soon as international travel and trade resume, reservoirs of COVID-19 and other vaccine-preventable diseases in LDFCAC will continue 'feeding' developed countries with repeated infection seeds. Assuring LDFCAC equity in access to medical countermeasures, funds to mitigate the pandemic, and a paradigm change in the global development agenda, similar to the post-World War II Marshall Plan for Europe, are urgently needed. We argue for a paradigm change in strategy, including a new global pandemic financing mechanism for COVID-19 and other future pandemics. This approach should assist LDFCAC in gaining access to and membership of a global interdisciplinary pandemic taskforce to enable in-country plans to train, leverage, and maintain essential functioning and also to utilize and enhance surveillance and early detection capabilities. Such a task force will be able to build on and expand research into the management of pandemics, protect vulnerable populations through international laws/treaties, and reinforce and align the development agenda to prevent and mitigate future pandemics. Lifting LDFCAC from COVID-related failure will offer the global community the best economic dividends of the century.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article